Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
ORD only    All VA Research websites

Office of Research & Development

print icon sign up for VA Research updates

Funded Project Details - FY2021




Project Number:

I01BX001137-05A2
Title: Reducing Nephrotoxicity while enabling read through of missense stop codons by Gentamicin congeners
Principal Investigator:

Robert L. Bacallao

Location: Indianapolis, IN
Congressional District Code: 7
Research Service: Biomedical Laboratory R&D
Project Period: April 2017 - March 2021
FY 2021 Funding Amount: $82,500
Total Award Amount
(all years):
$787,296
Abstract: View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER


Excerpt:

Aminoglycoside antibiotics remain first line therapy for gram negative infections and are used in conjunction with other antibiotics for certain gram positive organisms. Aminoglycosides, especially gentamicin, have also been used to suppress premature stop codon termination of protein synthesis leading to monogenic diseases like cystic fibrosis and Duchene's Muscular Dystrophy. Unfortunately, they still have an unacceptably high rate of dose and duration-dependent nephrotoxicity, especially in t...



Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.